Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Bigger in Benelux

How BioGeneration Ventures raised its largest fund to date

BioGeneration Ventures parlayed two major wins from its second fund into its largest fund to date, and now has the capital reserves for follow-on investments so the firm can retain more value in portfolio companies.

On Oct. 31, the Dutch

Read the full 391 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers